SPERO THERAPEUTICS, INC. SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 13th, 2019 • Spero Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJune 13th, 2019 Company Industry JurisdictionTHIS SECURITIES PURCHASE AGREEMENT (the “Agreement”) is made as of the 12th day of June, 2019, by and between Spero Therapeutics, Inc., a Delaware corporation (the “Company”), and Novo Holdings A/S, a Danish limited liability company (the “Investor”).